Technology | Magnetic Resonance Imaging (MRI) | September 06, 2017

CIRS Launches New MRI Distortion Check Software

Cloud-based solution quickly and automatically quantifies distortion in MRI images

CIRS Launches New MRI Distortion Check Software

September 6, 2017 — MRI Distortion Check is a new, cloud-based solution designed to quickly and automatically quantify distortion in magnetic resonance images (MRI). Used in conjunction with CIRS MRI Grid phantoms, the software provides the capability to quickly and accurately measure distortion through out the entire image volume.

After automatically detecting thousands of grid intersections, the software registers either a computer-aided detection (CAD) or computed tomography (CT) scan ground truth to these MR-detected control points. An interpolation is then performed to generate 3-D distortion vector fields.

Results can be reported in a variety of output formats including scatter plots, contour plots, box and whisker plots, and DICOM overlays that can be imported to treatment planning systems (TPS) or other third-party software. The software algorithms will work with any grid configuration, and CIRS employs proprietary 3-D printing techniques that enable easy modification of grid phantoms to meet customer requirements.

CIRS will display the MRI Distortion Check Software, along with the Model 604 Large Field MRI Distortion Phantom, and 603A MRI Skull Distortion Phantom, at the 2017 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 24-27 in San Diego.

For more information: www.cirsinc.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
Radcal Exhibits Accu-Gold Touch Systems at AAPM 2019
News | Radiation Dose Management | July 09, 2019
Radcal Corp. will be presenting the new Accu-Gold Touch platform, a multi-analyzer the company says is the latest in X-...